Fibroblastic reticular cell-derived exosomes are a promising therapeutic approach for septic acute kidney injury.

导出 LinkOut

翻译打印收藏纠错

作者： Yiming,Li ^[1] ; Chang,Hu ^[1] ; Pan,Zhai ^[2] ; Jing,Zhang ^[1] ; Jun,Jiang ^[1] ; Jinmeng,Suo ^[3] ; Bo,Hu ^[1] ; Jing,Wang ^[1] ; Xiaocheng,Weng ^[4] ; Xiang,Zhou ^[4] ; Timothy R,Billiar ^[5] ; John A,Kellum ^[6] ; Meihong,Deng ^[7] ; Zhiyong,Peng ^[8]

作者单位： Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; Clinical Research Center of Hubei Critical Care Medicine, Wuhan, China. ^[1] Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[2] Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. ^[3] College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, China. ^[4] Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. ^[5] Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. ^[6] Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, Manhasset, New York, USA. ^[7] Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; Clinical Research Center of Hubei Critical Care Medicine, Wuhan, China; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Intensive Care Unit of the second affiliated Hospital of Hainan Medical College, Haikou, Hainan, China. Electronic address: pengzy5@hotmail.com. ^[8]

关键词 CD5L NLRP3 inflammasome exosome mitophagy sepsis-induced acute kidney injury